<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhuang K</submitter><funding>Natural Science Foundation of Beijing Municipality</funding><funding>National Natural Science Foundation of China</funding><funding>China Postdoctoral Science Foundation</funding><pagination>526</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12482249</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) can reverse senescence after acute kidney injury (AKI) via maintaining mitochondrial homeostasis. Copper accumulation and STAT3 nuclear translocation promote senescence, but their mitochondrial localization in response to MSCs remains unclear.&lt;h4>Methods&lt;/h4>C57 mice with renal unilateral ischemia reperfusion injury (uIRI) were renal capsular transplanted with hUC-MSCs for two weeks to assessed treatment efficacy. Then, RNA sequencing, protein co-immunoprecipitation, molecular docking, and molecular dynamic simulation were used to found the relationship between senescence, mitochondrial translocation of STAT3 (mitoSTAT3), and copper homeostasis. Furthermore, inhibition of cMet/HGFR, mitoSTAT3, or COX17 were u</pubmed_abstract><journal>Stem cell research &amp; therapy</journal><pubmed_title>MSCs-derived HGF alleviates senescence after AKI by modulating mitoSTAT3-controlled copper flux and respiration.</pubmed_title><pmcid>PMC12482249</pmcid><funding_grant_id>82170686</funding_grant_id><funding_grant_id>2024M754288</funding_grant_id><funding_grant_id>7254312</funding_grant_id><funding_grant_id>No. 82200762</funding_grant_id><pubmed_authors>Zheng X</pubmed_authors><pubmed_authors>Feng Z</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Liang Y</pubmed_authors><pubmed_authors>Xu C</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Zhuang K</pubmed_authors><pubmed_authors>Cai G</pubmed_authors></additional><is_claimable>false</is_claimable><name>MSCs-derived HGF alleviates senescence after AKI by modulating mitoSTAT3-controlled copper flux and respiration.</name><description>&lt;h4>Background&lt;/h4>Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) can reverse senescence after acute kidney injury (AKI) via maintaining mitochondrial homeostasis. Copper accumulation and STAT3 nuclear translocation promote senescence, but their mitochondrial localization in response to MSCs remains unclear.&lt;h4>Methods&lt;/h4>C57 mice with renal unilateral ischemia reperfusion injury (uIRI) were renal capsular transplanted with hUC-MSCs for two weeks to assessed treatment efficacy. Then, RNA sequencing, protein co-immunoprecipitation, molecular docking, and molecular dynamic simulation were used to found the relationship between senescence, mitochondrial translocation of STAT3 (mitoSTAT3), and copper homeostasis. Furthermore, inhibition of cMet/HGFR, mitoSTAT3, or COX17 were u</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-07-15T09:49:53.62Z</modification><creation>2026-07-02T03:12:13.417Z</creation></dates><accession>S-EPMC12482249</accession><cross_references><pubmed>41024282</pubmed><doi>10.1186/s13287-025-04653-3</doi></cross_references></HashMap>